• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Hester Biosciences Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4164.0
  • ISIN : INE782E01017
2,193.80 245 (12.55%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    1,820.00

  • Today’s High

    2,338.00

  • Open

    1,945.00

  • Perv Close

    1,949.20

  • 52W Low

    1,242.95

  • 52W High

    3,257.35

Key Indicators

  • P/E(TTM)

    59.44

  • Mar.Cap (₹Cr.)

    1,866.24

  • Div & Yield %

    0.32

  • Book Value(₹)

    398.60

  • Debt-Equity Ratio

    12.55

  • AGM Date

    01-Aug-2025

  • EPS

    36.73

  • P/E Ratio

    59.44

Financials Ratios

  • Debt-Equity Ratio

    0.91

  • Mar.Cap (₹Cr.)

    1,866.24

  • RONW (%)

    7.41

  • ROCE (%)

    8.74

Score Board

  • Equity (₹ in Cr.)

    8.51

  • BV (₹)

    398.60

  • Sales( ₹ in Cr.)

    286.47

  • NP (in Cr.)

    32.19

  • NP Var(%)

    19.0

  • Div%

    70.0

  • CPS (₹)

    47.90

  • EPS (₹)

    37.80

  • Traded Value (₹ in Lakhs)

    1,857.18

  • 52 Week High

    3,257.35

  • 52 Week Low

    1,242.95

  • Price BSE

    2183.0

  • Price NSE

    2,194.00

  • Market Capital( in Cr.)

    1,857.18

  • P/C Ratio

    45.50

  • P/E Ratio

    57.70

  • Price Vs.BV

    37.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 286.47 285.16 254.00 219.35 208.48 169.43
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 286.47 285.16 254.00 219.35 208.48 169.43
Other Income 4.76 4.26 5.32 4.66 1.65 2.93
Stock Adjustments -9.97 -10.36 4.77 12.53 -4.01 15.57
Total Income 281.26 279.06 264.09 236.54 206.12 187.93
EXPENDITURE :            
Raw Materials 83.70 89.28 84.65 76.37 49.38 44.81
Power and Fuel Cost 10.12 12.34 9.95 8.74 6.93 7.29
Employee Cost 54.76 56.72 47.92 39.12 33.45 37.16
Other Manufacturing Expenses 14.07 14.49 7.57 6.89 5.46 6.19
Selling and Administration Expenses 54.45 50.25 49.26 34.94 32.24 32.88
Miscellaneous Expenses 8.46 4.37 4.55 5.26 10.28 3.95
Employee Benefit Expenses 54.76 56.72 47.92 39.12 33.45 37.16
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 225.56 227.45 203.88 171.31 137.74 132.28
Operating Profit 55.71 51.60 60.21 65.23 68.37 55.64
Interest 5.37 5.09 6.50 2.47 3.95 5.03
Gross Profit 50.34 46.51 53.71 62.76 64.42 50.61
Depreciation 8.58 9.78 9.79 9.50 9.63 9.39
Profit Before Tax 41.76 36.73 43.92 53.26 54.79 41.22
Current Tax 11.27 9.64 10.73 14.25 16.37 11.81
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.35 -0.06 0.86 -0.51 -1.48 -1.80
Reported Net Profit 31.84 27.16 32.34 39.52 39.90 31.22
Extraordinary Items -0.35 0.02 0.01 0.09 -3.69 0.38
Adjusted Net Profit 32.19 27.14 32.33 39.43 43.59 30.84
Adjustment below Net Profit -0.36 -0.02 0.11 -0.16 0.21 -1.63
P & L Balance brought forward 246.53 226.20 202.25 171.40 136.90 113.25
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 5.10 6.81 8.51 8.51 5.62 5.96
P & L Balance carried down 272.91 246.53 226.20 202.25 171.40 136.90
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 70.00 60.00 80.00 100.00 100.00 66.00
Dividend Per Share(Rs) 7.00 6.00 8.00 10.00 10.00 6.60
Earnings Per Share-Unit Curr 37.43 31.93 38.02 46.45 46.90 36.70
Earnings Per Share(Adj)-Unit Curr 37.43 31.93 38.02 46.45 46.90 36.70
Book Value 398.60 367.59 343.70 315.54 279.28 238.72
Book Value(Adj)-Unit Curr 398.60 367.59 343.70 315.54 279.28 238.72

Shareholding Pattern

  • Promoter Group

    53.73%

  • Public Share Holding

    46.27%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 803,955 803,955.00 803,955 803,955
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 803,955 9.45 803,955 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 336,838 3.96 336,838 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,430,151 40.32 3,430,151 8
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,766,989 44.28 3,766,989 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 3,700 0.04 3,700 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 40,289 0.47 40,289 15
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 151 0.00 151 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,500 0.02 1,500 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 45,640 0.54 45,640 21
2] Non Institution
Bodies Corporate 266,005 3.13 266,004 120
Clearing Members 14 0.00 14 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 517,902 6.09 517,902 387
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 216,804 2.55 216,704 345
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,237,827 14.55 1,237,827 16
Individuals holding nominal share capital up to Rs. 1 lakh 1,552,320 18.25 1,487,753 10,889
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,649 0.03 2,649 2
Others 83,652 0.98 83,652 1
Sub Total 3,890,281 45.73 3,825,613 11,776
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 8,506,865 100.00 8,442,197 11,810

Company Background

Hester Biosciences LtdPharmaceuticals - Indian - Formulations

  • Hester Biosciences Ltd
  • BSE Code : 4164.0
  • ISIN : INE782E01017

  • Incorporation Year

    1987

  • Registered Office

    1st Flr PushpakPachvati Circle
    Motilal Hirabhai Road, Ahmedabad,
    Gujarat-380006

  • Telephone

    91-079-26445107

  • FAX

    91-079-26445105

  • Chairman

    Bhupendra V Gandhi

  • Managing Director

    Rajiv D Gandhi

  • Company Secretary

  • Auditor

    Chandulal M Shah & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road,Navrangpura
    Mumbai - Ahmedabad-380009

Hester Biosciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Hester Bios 2,183.15 291.23 286.47 59.44 9.47
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10